Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
Conditions: Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction; Amyloid Cardiomyopathy Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Condition: Depressive Disorder Interventions: Drug: Fluoxetine 20 mg; Drug: Dapagliflozin 10mg Tab; Drug: Atorvastatin 80mg Sponsors: Tanta University; Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Fedaa Abd El-monem Kamal El-deen Kotkata Faculty of Pharmacy, Tanta University; Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2023 Category: Research Source Type: clinical trials